Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors

This study has been withdrawn prior to enrollment.

Sponsor:

Collaborator:

Information provided by:

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00227773

First received: September 26, 2005

Last updated: October 24, 2006

Last verified: October 2006

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given